Profile of acne patients in the Philippines requiring a second course of oral isotretinoin

International Journal of Dermatology

Volumn 44, Issue 12, 2005, Pages 999-1001

  Haryati, Indra ^a   Jacinto, Sylvia S ^a,b  

^a Skin and Cancer Foundation Inc   (Philippines)

^b NONE   (Philippines)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI ACNE AGENT; ANTIBIOTIC AGENT; ISOTRETINOIN;

ACNE VULGARIS; ADOLESCENT; ADULT; AGE; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REGIMEN; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PHILIPPINES; RELAPSE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ACNE VULGARIS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; ISOTRETINOIN; MALE; PHILIPPINES; RECURRENCE; TREATMENT OUTCOME;

EID: 30044443606     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2005.02284.x     Document Type: Article

References (20)

1. Landaw K. Dispelling myths about acne. Postgrad Med 1997; 102: 94-99, 103-4, 110-2.
2. Ellis CN, Krach KJ. Uses and complication of isotretinoin therapy. J Am Acad Dermatol 2001; 45: S150-S157.
3. CDC. Accutane® - exposed pregnancies - California 1999. MMWR 2000; 49 (2): 28-31.
4. Wysowski DK, et al. Use of isotretinoin (Accutane) in the United States: Rapid increase from 1992 through 2000. J Am Acad Dermatol 2000; 46: 505-509.
5. Johnson BA, Nunley JR. Use of systemic agents in the treatment of acne vulgaris. Am Fam Physician 2000; 62: 1823-30, 1835-1836.
6. Cunliffe. WJ, et al. Roaccutane treatment guidelines: Result of an international survey. Dermatology 1997; 194: 351-357.
7. Isotretinoin. Patient Information Handout: www.geocities.com/Athens/Ithaca/3427/ptinfo.htm.
8. Roaccutane Information. Info from Dr. Kaminer: www.geocities.com/beat_acne/roaccutane.html.
9. Layton AM, Cunliffe WJ. Guidelines for optimal use of isotretinoin in acne. J Am Acad Dermatol 1992 27 (6 N2); S2-S7.
10. Layton AM, Knaggs HT, Cunliffe WJ. Isotretinoin for acne vulgaris - 10 years: a safe and successful treatment. Br J Dermatol 1993; 129 (3): 292-296.
11. Stainfort JM, et al. Isotretinoin for treatment of acne vulgaris: which factors may predict the need for more than one course? Br J Dermatol 1993; 129: 297-301.
12. Peck GL. Retinoids. In: Freedberg L, Eisen A, Wolff K, et al., ed. Fitzpatrick's Dermatology in General Medicine, 5th edn. 2000; 2810-2812.
13. Health Drug Index: Accutane, Copyright 2002 Thomson Health-Care: www.CTCL.consult.com.
14. Saurat JH. Experience with isotretinoin in the treatment of Acne. Dermatologica 2002; 176: 191-199.
15. White GM, Chen W, et al. Recurrence rate after the first course of isotretinoin, archives of dermatology. 1998; 134: 376-378.
16. Strauss JS, et al. A randomized trial of the efficacy of a new micronized formulation versus a standard formulation of isotretinoin in patients with severe recalcitrant nodular acne. J Am Acad Dermatol 2001; 45: 187-195.
17. Cunliffe WJ, Norris JF. Isotretinoin - an explanation for its longterm benefit. Dermatologica 1987; 175 S1 133-137.
18. Helwick C. AAD consensus conference on isotretinoin yields statement. Dermatology World 2002; 12: 1 & 19.
19. Jacinto-Jamora S, Tamesis J, et al. Pityrosporum folliculitis Philippines: diagnosis, prevalence, management. J Am Acad Dermatol 1991; 24: 693-696.
20. Lehucher CD, de la Salmoniere P et al. Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients. Dermatology 1999; 198: 278-283.